logo

Tenax Therapeutics Inc (TENX)



Trade TENX now with
  Date
  Headline
3/11/2019 8:33:40 AM Tenax Enrolls First Patient For Phase 2 Pulmonary Hypertension Clinical Trial
12/11/2018 4:05:32 PM Tenax Therapeutics Closes $10 Mln Underwritten Offering
8/28/2018 8:36:02 AM Tenax Therapeutics: Clinical Study Results Say Levosimendan Offers Renal Protective Benefits To Heart Failure Patients
6/5/2018 4:36:56 PM Tenax Therapeutics Appoints Anthony DiTonno As CEO
6/1/2018 8:37:54 AM Tenax Therapeutics Reports Study Design For Phase 2 Trial Of Levosimendan In PH-HFpEF Patients
4/4/2018 8:05:44 AM Tenax Therapeutics Announces Results Of Pre-IND Meeting With FDA For Phase 2 Study Of Levosimendan In PH-HFpEF Patients
3/14/2018 8:03:41 AM Tenax Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
3/1/2018 8:46:16 AM Tenax Announces Publication Of A Positive Preclinical Study Of Levosimendan Conducted By Hansen Et Al
  
 
>